Pharmacovigilance Market by Clinical Trial Phase (Pre-Clinical, Phase I, and Phase II, Phase III, and Phase IV); By Service Provider (In-House, and Contract Outsourcing); By Method (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, and EHR Mining); By End-Use (Hospitals, Research Organizations, and Industrial); By Geography (North America, Asia-Pacific, Europe, South America, and RoW), Industry Trends, Estimation & Forecast, 2018 – 2026

TABLE OF CONTENTS Chapter 1 Introduction 1.1 Executive Summary 1.2 Market Definition 1.3 Market Scope Chapter 2 Research Methodology 2.1 Primary Research 2.2 Research Methodology 2.3 Assumptions & Exclusions 2.4 Secondary Data Sources Chapter 3 Market Overview 3.1 Report Segmentation & Scope 3.2 Key Market Trends 3.2.1 Drivers 3.2.2 Restraints 3.2.3 Opportunities 3.3 Porter’s Five Forces Analysis 3.4 Market Share Analysis Chapter 4 Global Pharmacovigilance Market by Clinical Trial Phase: Market Size and Forecast, 2018 – 2026 4.1 Introduction 4.1.1 Market Size and Forecast 4.2 Pre-Clinical 4.2.1 Market Size and Forecast 4.3 Phase I 4.3.1 Market Size and Forecast 4.4 Phase II 4.4.1 Market Size and Forecast 4.5 Phase III 4.5.1 Market Size and Forecast 4.6 Phase IV 4.6.1 Market Size and Forecast Chapter 5 Global Pharmacovigilance Market by Service Provider: Market Size and Forecast, 2018 – 2026 5.1 Introduction 5.1.1 Market Size and Forecast 5.2 In-House 5.2.1 Market Size and Forecast 5.3 Contract Outsourcing 5.3.1 Market Size and Forecast Chapter 6 Global Pharmacovigilance Market by Method: Market Size and Forecast, 2018 – 2026 6.1 Introduction 6.1.1 Market Size and Forecast 6.2 Spontaneous Reporting 6.2.1 Market Size and Forecast 6.3 Intensified ADR Reporting 6.3.1 Market Size and Forecast 6.4 Targeted Spontaneous Reporting 6.4.1 Market Size and Forecast 6.5 Cohort Event Monitoring 6.5.1 Market Size and Forecast 6.6 EHR Mining 6.6.1 Market Size and Forecast Chapter 7 Global Pharmacovigilance Market by End-Use: Market Size and Forecast, 2018 – 2026 7.1 Introduction 7.1.1 Market Size and Forecast 7.2 Hospital 7.2.1 Market Size and Forecast 7.3 Research Organizations 7.3.1 Market Size and Forecast 7.4 Industrial 7.4.1 Market Size and Forecast Chapter 8 Global Pharmacovigilance Market by Geography: Market Size and Forecast, 2018 – 2026 8.1 Introduction 8.1.1 Market Size and Forecast 8.2 North America 8.2.1 North America Market Size & Forecast, By Country 8.2.2 North America Market Size & Forecast, By Clinical Trial Phase 8.2.3 North America Market Size & Forecast, By Service Provider 8.2.4 North America Market Size & Forecast, By Method 8.2.5 North America Market Size & Forecast, By End-Use 8.2.6 The U.S. 8.2.6.1 Market Size and Forecast 8.2.7 Canada 8.2.7.1 Market Size and Forecast 8.2.8 Mexico 8.2.8.1 Market Size and Forecast 8.3 Europe 8.3.1 Europe Market Size and Forecast, By Country 8.3.2 Europe Market Size and Forecast, By Clinical Trial Phase 8.3.3 Europe Market Size and Forecast, By Service Provider 8.3.4 Europe Market Size and Forecast, By Method 8.3.5 Europe Market Size & Forecast, By End-Use 8.3.6 UK 8.3.6.1 Market Size and Forecast 8.3.7 Germany 8.3.7.1 Market Size and Forecast 8.3.8 France 8.3.8.1 Market Size and Forecast 8.3.9 Italy 8.3.9.1 Market Size and Forecast 8.3.10 Spain 8.3.10.1 Market Size and Forecast 8.3.11 Rest of Europe 8.3.11.1 Market Size and Forecast 8.4 Asia-Pacific 8.4.1 Asia-Pacific Market Size and Forecast, By Country 8.4.2 Asia-Pacific Market Size and Forecast, By Clinical Trial Phase 8.4.3 Asia-Pacific Market Size and Forecast, By Service Provider 8.4.4 Asia-Pacific Market Size and Forecast, By Method 8.4.5 Asia-Pacific Market Size and Forecast, By End-Use 8.4.6 India 8.4.6.1 Market Size and Forecast 8.4.7 China 8.4.7.1 Market Size and Forecast 8.4.8 Australia 8.4.8.1 Market Size and Forecast 8.4.9 Japan 8.4.9.1 Market Size and Forecast 8.4.10 South Korea 8.4.10.1 Market Size and Forecast 8.4.11 Rest of Asia-Pacific 8.4.11.1 Market Size and Forecast 8.5 South America 8.5.1 South America Market Size and Forecast, By Country 8.5.2 South America Market Size and Forecast, By Clinical Trial Phase 8.5.3 South America Market Size and Forecast, By Service Provider 8.5.4 South America Market Size and Forecast, By Method 8.5.5 South America Market Size and Forecast, By End-Use 8.5.6 Brazil 8.5.6.1 Market Size and Forecast 8.5.7 Rest of South America 8.5.7.1 Market Size and Forecast 8.6 RoW 8.6.1 RoW Market Size and Forecast, By Country 8.6.2 RoW Market Size and Forecast, By Clinical Trial Phase 8.6.3 RoW Market Size and Forecast, By Service Provider 8.6.4 RoW Market Size and Forecast, By Method 8.6.5 RoW Market Size and Forecast, By End-Use 8.6.6 Middle East 8.6.6.1 Market Size and Forecast 8.6.7 Africa 8.6.7.1 Market Size and Forecast Chapter 9 Company Profiles 9.1 Accenture 9.2 Capgemini 9.3 Cognizant 9.4 IBM Corporation 9.5 ICON plc 9.6 IQVIA (Quintiles IMS) 9.7 ITClinical 9.8 Laboratory Corporation of America Holdings 9.9 PAREXEL International Corporation 9.10 TCS 9.11 United BioSource Corporation 9.12 Wipro Ltd.